Some research suggests that GLP-1 drugs may raise the risk of a rare eye disease that causes full or partial vision loss.
Mostramos la idea principal publicamente. Crea una cuenta gratis para seguir leyendo el articulo completo, guardarlo, comentarlo y conectarlo con contexto de mercados y OSINT.